BioPharm News

Oct 17, 2017
By BioPharm International Editors
DSM Sinochem Pharmaceuticals has filed a lawsuit against CSPC Pharmaceutical Group, Inner Mongolia Changsheng Pharmaceutical Company, and CSPC Zhangnuo Pharmaceutical (Shijiazhuang) for infringement of its amoxicillin patent.
Oct 17, 2017
By BioPharm International Editors
Almac Group’s Almac Pod, a temperature-controlled shipping solution service for biologics and other temperature-sensitive products, is available in the United States.
Oct 17, 2017
By BioPharm International Editors
The agency has published a continuity plan for its move from the United Kingdom.
Oct 16, 2017
By BioPharm International Editors
The company announced plans to expand its viral vector process development facilities in the United States and its cleanroom facilities in the Netherlands for vector-based products.
Oct 16, 2017
By BioPharm International Editors
The Belgian biopharmaceutical company has formed a subsidiary in the United States, and appointed Daniel Schneider as its general manager.
Oct 16, 2017
By BioPharm International Editors
Through the support of the Japanese agency, Daiichi Sankyo intends to further develop its genetic vaccine platform focused around its new nucleic acid delivery technology.
Oct 16, 2017
By BioPharm International Editors
The new center will serve as a regional hub where scientists and engineers can work with customers for biological development.
Oct 16, 2017
By BioPharm International Editors
Stelara (ustekinumab), already approved for treating adults, is now also approved for treating adolescents with moderate to severe plaque psoriasis.
Oct 16, 2017
By BioPharm International Editors
The companies will collaborate to produce and improve the recombinant properties of Aethlon’s Hemopurifier blood purification device.
Oct 16, 2017
By BioPharm International Editors
The vaccine is a non-live, recombinant subunit vaccine that combines an antigen and an adjuvant system to trigger a targeted and long-lasting immune response to the shingle-causing virus.
native1_300x100
lorem ipsum